Viking Therapeutics COO Marianna Mancini's Stock Transactions

Marianna Mancini, Chief Operating Officer of Viking Therapeutics, Inc., reported two significant stock transactions. On October 27, 2025, she acquired 11,117 shares of common stock at $0 per share, increasing her total holdings to 388,652 shares. This acquisition was part of a performance restricted stock unit award granted on January 3, 2025, which vested upon the achievement of non-financial performance goals. On October 28, 2025, she sold 6,185 shares at a weighted average price of $35.0027 per share, reducing her holdings to 382,467 shares. The sale was conducted to satisfy tax withholding obligations related to the vesting of the stock units. The transactions were reported in a Form 4 filing with the SEC.